Wuhan Keqian Biology Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000042Q8
CNY
12.18
-0.2 (-1.62%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
946.07
938.48
1,057.23
997.42
1,098.86
840.14
505.76
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
946.07
938.48
1,057.23
997.42
1,098.86
840.14
505.76
Raw Material Cost
332.68
359.48
318.91
288.19
241.25
161.44
122.15
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
186.44
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.15
4.97
8.30
5.60
2.62
0.77
0.05
Selling and Distribution Expenses
145.88
179.20
290.90
236.59
206.63
156.74
115.91
Other Expenses
-9.97
7.19
6.96
8.68
6.89
5.09
4.17
Total Expenditure (Excl Depreciation)
565.43
615.59
687.70
617.17
519.44
369.89
279.83
Operating Profit (PBDIT) excl Other Income
380.6
322.9
369.5
380.20000000000005
579.4
470.3
225.9
Other Income
83.84
108.06
118.75
100.78
85.02
55.66
55.09
Operating Profit (PBDIT)
563.39
525.60
587.30
568.46
724.49
560.24
315.50
Interest
0.15
4.97
8.30
5.60
2.62
0.77
0.05
Exceptional Items
32.04
27.35
-6.92
1.44
0.82
-2.78
0.00
Gross Profit (PBDT)
613.40
579.00
738.33
709.23
857.62
678.70
383.60
Depreciation
113.73
109.83
114.50
97.69
62.64
37.03
37.15
Profit Before Tax
481.54
438.13
457.58
466.61
660.05
519.66
278.30
Tax
64.60
56.64
62.00
57.46
89.41
71.86
35.66
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
418.72
382.35
395.93
409.52
570.74
447.80
242.64
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
418.72
382.35
395.93
409.52
570.74
447.80
242.64
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.78
-0.86
-0.35
-0.37
-0.11
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
416.94
381.49
395.58
409.15
570.64
447.80
242.64
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,238.78
3,940.97
3,835.63
3,496.95
3,153.48
2,708.52
1,118.98
Earnings per share (EPS)
0.9
0.82
0.85
0.88
1.23
0.96
0.52
Diluted Earnings per share
0.9
0.82
0.85
0.88
1.23
0.96
0.52
Operating Profit Margin (Excl OI)
38.67%
32.79%
33.49%
37.09%
52.49%
55.65%
44.14%
Gross Profit Margin
62.92%
58.39%
54.11%
56.58%
65.77%
66.26%
62.37%
PAT Margin
44.26%
40.74%
37.45%
41.06%
51.94%
53.3%
47.98%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 0.81% vs -11.23% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 9.28% vs -3.56% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 14.85% vs -10.89% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -96.00% vs -39.76% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Wuhan Keqian Biology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
946.07
0
946.07
Other Operating Income
0.00
0.00
0.00
Total Operating income
946.07
0
946.07
Raw Material Cost
332.68
0
332.68
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
186.44
0
186.44
Power Cost
0
0
0.00
Manufacturing Expenses
0.15
0
0.15
Selling and Distribution Expenses
145.88
0
145.88
Other Expenses
-9.97
0.00
-9.97
Total Expenditure (Excl Depreciation)
565.43
0
565.43
Operating Profit (PBDIT) excl Other Income
380.64
0.00
380.64
Other Income
83.84
0
83.84
Operating Profit (PBDIT)
563.39
0
563.39
Interest
0.15
0
0.15
Exceptional Items
32.04
0
32.04
Gross Profit (PBDT)
613.40
0
613.40
Depreciation
113.73
0
113.73
Profit Before Tax
481.54
0
481.54
Tax
64.60
0
64.60
Provisions and contingencies
0
0
0.00
Profit After Tax
418.72
0
418.72
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
418.72
0
418.72
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.78
0
-1.78
Other related items
0.00
0.00
0.00
Consolidated Net Profit
416.94
0
416.94
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,238.78
0
4,238.78
Earnings per share (EPS)
0.90
0
0.90
Diluted Earnings per share
0.90
0
0.90
Operating Profit Margin (Excl OI)
38.67%
0%
0.00
38.67%
Gross Profit Margin
62.92%
0%
0.00
62.92%
PAT Margin
44.26%
0%
0.00
44.26%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 94.61 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 0.81% vs -11.23% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 41.69 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 9.28% vs -3.56% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 47.95 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 14.85% vs -10.89% in Dec 2024

Annual - Interest
Interest 0.02 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -96.00% vs -39.76% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 38.67%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024